Rite Aid’s bankruptcy wound down roughly 1,250 stores in 2025. Walgreens shuttered around 500 the same year, partway into a plan to close 1,200 over three years, and CVS closed another 270 on top of some 900 in the years just before. Add it up and about 2,000 pharmacy locations vanished from three chains in a single year.
Stretch the window to four years and the three largest chains have closed almost 3,000 locations nationwide, according to the 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. GoodRx research puts roughly one in seven Americans in a pharmacy desert already, defined as needing a drive of fifteen minutes or more to reach a pharmacy counter. Deserts were spreading before this cycle began; the 2025 wave carved them deeper and pushed new neighborhoods past the threshold.
Jocelyn Freimuth watches the closure wave from the advisory side of the business. Co-Founder and CEO of Camino Compass, a Nashville healthcare consulting and management firm that works with pharmacies, clinics, and telehealth organizations across the country, she spends her weeks inside the operations of the pharmacies still standing. Closure headlines read as retail news, she argues, when they should read as care interruptions.
The Economics Behind the Empty Storefronts
Prescription margins have thinned for years while the costs of staffing and real estate moved the other way. Chains responded the way retailers respond, by pruning underperforming locations, and the map absorbed the consequences. Modern Retail’s reporting traces where the volume went: online delivery platforms, grocery chains, warehouse clubs, and convenience retailers expanding pharmacy operations into the gap.
Independents face the same squeeze without a corporate balance sheet behind them. A single store cannot subsidize a bad reimbursement year from a thousand sister locations. What it can do, and what the surviving chains cannot, is change its service mix faster than a national retail plan allows.
Every closure also redraws the workload map for whoever remains. Thousands of prescriptions transfer at once to the nearest surviving counters, stretching staff, lengthening waits, and pushing some of those pharmacies toward the same breaking point. Closure risk travels through a neighborhood the way load travels through a weakened structure, concentrating on whatever still stands. Chains will keep optimizing their maps; neighborhoods cannot.
What Disappears When the Counter Goes Dark?
A closed pharmacy takes more than its inventory with it. Jocelyn Freimuth counts four losses that land hardest:
- Walk-in advice, the unscheduled question about an interaction or a side effect that never becomes an appointment anywhere else
- Immunization access, which for many neighborhoods runs almost entirely through the pharmacy
- Continuity, since transferred prescriptions mean new records, new staff, and new chances for a refill to slip
- A public-health lookout, because the person who notices a patient rationing doses is usually behind that counter
Distance compounds each loss. Research in Greater Boston counts nearly 15,000 residents in pharmacy deserts under an urban standard, living at least half a mile from the nearest drugstore in households without a vehicle. Fifteen minutes by car in a rural county and half a mile on foot in a city describe the same fact: the medication is now somewhere the patient is not.
Cost pressure stacks on top of the travel burden. Researchers studying closures describe patients weighing groceries against refills once reaching a pharmacy becomes its own expense, and a skipped maintenance medication rarely announces itself until the emergency room visit it caused. Distance converts a manageable condition into an untreated one quietly, one missed refill at a time.
The Survival Math Jocelyn Freimuth Runs With Independents
Advice for the pharmacies still open starts with revenue concentration. “A pharmacy that only fills prescriptions has one revenue line and one reason to exist,” Jocelyn Freimuth says. “The ones that survive give their community three or four.”
Diversification in practice means clinical services, immunization programs, point-of-care testing, and partnerships with local clinics and employers. Each added service builds a second argument for the storefront’s existence, and each argument makes the next reimbursement cut less existential. Compliance footing matters just as much, since a licensure lapse or a failed inspection can end a thin-margin operation faster than any competitor. Margins forgive nothing, so sequencing counts: stabilize the license and the workflow first, add services second, and market what works third.
Her firm’s client work runs through exactly that checklist: operational reviews, licensing support, and training that keeps a small staff current without a corporate education department behind it. Jocelyn Freimuth’s argument to owners is that resilience is an operations project rather than a marketing one. Inventory discipline, payer contract terms, workflow design, and staff cross-training decide whether a good clinical idea survives contact with a payroll cycle.
Location strategy gets the same scrutiny. A storefront inheriting patients from a shuttered chain store needs capacity ready before the transfer wave hits, while a store in a thinning market may need a delivery route, a clinic partnership, or a consolidation plan instead. Growth and retreat both go better planned than improvised.
Who Fills the Void, and What Gets Lost
Mail order and grocery counters will absorb most of the displaced prescriptions. Volume, though, was never the whole product. A shipped bottle answers no questions, notices no confusion, and catches no early warning signs. Substitution handles the logistics of a closed pharmacy and misses its judgment, and the mismatch is worst for cold-chain products, controlled substances, and the same-day antibiotic a sick patient needs before tonight.
Some of the void may refill from below. Lower rents in vacated storefronts, communities newly aware of what they lost, and a service mix chains never attempted give independents an opening that did not exist five years ago. Openings are not guarantees, and the operators who take them will need the multi-line model rather than the one it replaced.
Two indicators will show which way the map bends. Watch whether vacated pharmacy real estate reopens as independent practice or converts permanently to other retail, and watch whether payers start pricing pharmacy access itself, paying differently where a counter is the last one for miles. Either signal would tell owners more than another quarter of closure headlines will.
Jocelyn Freimuth reads a closure list the way an engineer reads a bridge report, as infrastructure news that arrives before the failure does. Communities tend to notice infrastructure only once it is gone. Jocelyn Freimuth’s point to the pharmacies still standing is that the work of staying open starts years before any sign comes down.
